Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Sygnature Discovery proves commitment to cyber security

Sygnature Discovery has proven its commitment to cyber security and the protection of its clients’ data by obtaining Cyber Essentials Plus certification.

Launched by the UK Government in 2014, Cyber Essentials is part of the Government’s National Cyber Security Strategy and aims to help organisations protect themselves against common cyber-attacks, demonstrate their commitment to cyber security and mitigate the risks from internet-based threats. Sygnature Discovery gained Cyber Essentials certification in 2016 and has now opted to up-grade to Cyber Essentials Plus certification as it offers a higher level of assurance of its cyber security approach through external verification by independent experts.

Sygnature Discovery’s IT infrastructure underwent a rigorous assessment conducted by Indelible Data Limited, a recognised Cyber Essentials Plus certification body, which evaluated the company’s use of technical controls including boundary firewalls and internet gateways, secure configuration, user access control, malware protection and patch management.

By achieving this accreditation, Sygnature Discovery is demonstrating to clients and stakeholders that it is taking crucial precautions to combat internet-borne threats and protect their high-value data. To maintain its Cyber Essentials Plus credentials, Sygnature Discovery will be reassessed annually and will continue to evolve its data systems and cyber security strategy.

Chief Operating Officer at Sygnature Discovery, Dr Jonathan Williams, said:

“We are delighted to be Cyber Essentials Plus certified and therefore recognised for our efforts in maintaining our IT systems and ensuring data integrity and confidentiality at Sygnature Discovery. We have customers located around the world, and the mitigation of internet-based threats is at the heart of how we do business. Sygnature understands the importance of cyber security and our clients can rest assured that we are taking all reasonable steps to protect their valuable data.”


Latest News

View All

Sygnature Discovery Adopts OpenEye’s Orion™ Platform to…

Sygnature Discovery shortlisted for BioNow Company of…

Sygnature upgrades western blotting capability with Jess…

Dr Paul Overton becomes Chief Commercial Officer…

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.